BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14621363)

  • 1. What do I tell my patients about drinking water and the risk of bladder cancer?
    Moyad MA
    Urol Nurs; 2003 Oct; 23(5):371-7. PubMed ID: 14621363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
    Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
    Chen YC; Su HJ; Guo YL; Houseman EA; Christiani DC
    Cancer Causes Control; 2005 Mar; 16(2):75-81. PubMed ID: 15868449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrate in public water supplies and risk of bladder cancer.
    Ward MH; Cantor KP; Riley D; Merkle S; Lynch CF
    Epidemiology; 2003 Mar; 14(2):183-90. PubMed ID: 12606884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan.
    Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Wang YH; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):101-10. PubMed ID: 20056628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
    Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-control study of male cancer patients exposed to arsenic-contaminated drinking water and tobacco smoke with relation to non-exposed cancer patients.
    Wadhwa SK; Kazi TG; Kolachi NF; Afridi HI; Khan S; Chandio AA; Shah AQ; Kandhro GA; Nasreen S
    Hum Exp Toxicol; 2011 Dec; 30(12):2013-22. PubMed ID: 21558145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
    Yang CY; Chiu HF; Chang CC; Ho SC; Wu TN
    Environ Res; 2005 May; 98(1):127-32. PubMed ID: 15721893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder cancer clusters in Florida: identifying populations at risk.
    Nieder AM; MacKinnon JA; Fleming LE; Kearney G; Hu JJ; Sherman RL; Huang Y; Lee DJ
    J Urol; 2009 Jul; 182(1):46-50; discussion 51. PubMed ID: 19450849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley.
    Knobeloch LM; Zierold KM; Anderson HA
    J Health Popul Nutr; 2006 Jun; 24(2):206-13. PubMed ID: 17195561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA.
    Slotnick MJ; Meliker JR; Nriagu JO
    J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):149-57. PubMed ID: 17426735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
    Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS
    J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL; Tannenbaum SR; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer epidemiology and pathogenesis.
    Ross RK; Jones PA; Yu MC
    Semin Oncol; 1996 Oct; 23(5):536-45. PubMed ID: 8893866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical reconstruction of wastewater and land use impacts to groundwater used for public drinking water: exposure assessment using chemical data and GIS.
    Swartz CH; Rudel RA; Kachajian JR; Brody JG
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):403-16. PubMed ID: 12973368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer: a selected review of the epidemiological literature.
    Pirastu R; Iavarone I; Comba P
    Ann Ist Super Sanita; 1996; 32(1):3-20. PubMed ID: 8967723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arsenic as an environmental problem].
    Jensen K
    Ugeskr Laeger; 2000 Dec; 162(49):6672-5. PubMed ID: 11188053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic and bladder cancer: observations and suggestions.
    Radosavljević V; Jakovljević B
    J Environ Health; 2008 Oct; 71(3):40-2. PubMed ID: 18990932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on the relationship between drinking water with high arsenic content and incidence of malignant tumour in Heihe Village, western part of Huhehot, Inner Mongolia].
    Luo FJ; Luo ZD; Ma L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):289-91. PubMed ID: 8706097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer and exposure to arsenic in rural Bangladesh.
    Mostafa MG; McDonald JC; Cherry NM
    Occup Environ Med; 2008 Nov; 65(11):765-8. PubMed ID: 18417558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.